Drawing for INNOSELF

USPTO serial 79297737

INNOSELF

Reviewed by CopyMark Law Group

Reg. 6564701Status 700Renewal
Filing date
Status date
Registration date
Nov 23, 2021
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INNOSELF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments for treating chronic renal failure, angina, myocardial infarction, organ transplant and reconstruction, nasolacrimal duct obstruction, dry eye syndrome, glaucoma, rhinoplasty, breast implant, biliary duct cancer, dental implant, denture, knee arthritis, hip arthritis, shoulder arthritis; medical instruments for treating dry eye syndrome, glaucoma; medical apparatus for treating dry eye syndrome, glaucoma; stents; medical stents; biocompatible coated stents; implantable urethral stents; self-expanding vascular stents; cardiovascular instruments, namely, medical instruments for treating or diagnosing angina, myocardial infarction; medical devices, namely, intravascular implants comprised of artificial material; prosthetic tissues for parietal/visceral and vascular use; tubes for perfusion for treating nasolacrimal duct obstruction, glaucoma; tubes for surgical purposes for treating nasolacrimal duct obstruction, glaucoma; tubes for medical purposes for treating nasolacrimal duct obstruction, glaucoma; medical devices, namely, expandable braids for insertion in bile ducts for treating stenosis; medical devices, namely, expandable braids for insertion in oesophagus for the treatment of stenosis; medical devices, namely, expandable braids for insertion in tubular organs of the body for the treatment of stenosis; medical devices, namely, expandable braids for insertion in blood vessels for treating stenosis; catheters; tubing for use with cathetersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 12, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
May 12, 2022FIMPFINAL DISPOSITION PROCESSED
Feb 23, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 5, 2021GPNXNOTIFICATION PROCESSED BY IB
Aug 18, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2021ALIEASSIGNED TO LIE
Aug 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 27, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2021RFNTREFUSAL PROCESSED BY IB
Feb 24, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 24, 2021RFRRREFUSAL PROCESSED BY MPU
Feb 20, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021DOCKASSIGNED TO EXAMINER
Nov 20, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Nov 16, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance